← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2000Last known activity
Feb 28, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05217719CollaboratorPhase 4Feb 28, 2022
- NCT03815448CollaboratorN/AMar 31, 2019
- NCT02247973CollaboratorPhase 2Feb 1, 2013
- NCT01717729Lead sponsorPhase 3Jan 1, 2000
- NCT01717729Reponsible party - principal investigatorPhase 3Jan 1, 2000
Details
- Last known activity
- Feb 28, 2022